The DABOM

The Decisive and Advanced
Bio-Operator for Medicine

The Decisive and
Advanced Bio-Operator
for Medicine

The DABOM Inc. is a specialized platform company that
mass-produces artificial exosomes using microfluidics
technology and artificial intelligence(AI).

More View
diagnostics

Technology

diagnostics

Artificial Exosomes
for Nanomedicine (ExocureTM)

Detail View
diagnostic kit

Artificial Exosome Mass-Producing Platform
(ExostationTM)

Detail View
diagnostic kit

Products/Service

Detail View

Pipeline - R&D Schedule

Exosome-based therapeutics

Detail View

The DABOM Notice

The DABOM Inc. at CES 2025

2025-01-10

The DABOM Inc. at CES 2025
Get a Sneak Peek of the CES 2025 Seoul Pavilion IR Pitching! play icon

2025-01-04

Get a Sneak Peek of the CES 2025 Seoul Pavilion IR Pitching!
CEO Hyo-Il Jung Attends SUP Family Day

2024-12-18

CEO Hyo-Il Jung Attends SUP Family Day
The DABOM Inc. to Showcase at [CES 2025 Seoul Pavilion]

2024-12-18

The DABOM Inc. to Showcase at [CES 2025 Seoul Pavilion]
CFO Jong-Ho Park Receives Commendation from the Minister of SMEs and Startups

2024-12-11

CFO Jong-Ho Park Receives Commendation from the Minister of SMEs and Startups
CEO Hyo-Il Jung Delivers Invited Lecture at the 2024 Korean Society for Extracellular Vesicles Annua

2024-09-04

CEO Hyo-Il Jung Delivers Invited Lecture at the 2024 Korean Society for Extracellular Vesicles Annua
The DABOM Inc. Signs MOU with PlantForm Corp. for Therapeutic Artificial Exosome Technology Developm

2024-07-31

The DABOM Inc. Signs MOU with PlantForm Corp. for Therapeutic Artificial Exosome Technology Developm
CEO Hyo-Il Jung Delivers Keynote Address at the International Conference on Nanotechn

2024-07-17

CEO Hyo-Il Jung Delivers Keynote Address at the International Conference on Nanotechn
The DABOM Inc. Attends the 2024 EVIA Annual General Meeting

2024-02-01

The DABOM Inc. Attends the 2024 EVIA Annual General Meeting
The DABOM Inc. Presents Two Research Findings Orally at the 2023 Korean Society for Extracellular Ve

2023-11-14

The DABOM Inc. Presents Two Research Findings Orally at the 2023 Korean Society for Extracellular Ve
CEO Hyo-Il Jung Receives the KSEV Achievement Award

2023-11-14

CEO Hyo-Il Jung Receives the KSEV Achievement Award
The DABOM Inc. Signs MOU with One BioMed Pte. Ltd. for the Development of Ultra-Rapid Exosome Analys

2023-10-31

The DABOM Inc. Signs MOU with One BioMed Pte. Ltd. for the Development of Ultra-Rapid Exosome Analys
The DABOM Inc. Signs MOU with KIST Europe for European Market Entry

2023-10-26

The DABOM Inc. Signs MOU with KIST Europe for European Market Entry
The Dabom Co., Ltd. Awarded Top Honors in Yonsei University’s Lab Startup Program

2023-07-12

The Dabom Co., Ltd. Awarded Top Honors in Yonsei University’s Lab Startup Program
CEO Hyo-Il Jung Delivers Invited Lecture and Oral Presentation at the APSEV Conference

2023-04-03

CEO Hyo-Il Jung Delivers Invited Lecture and Oral Presentation at the APSEV Conference
CEO Hyo-Il Jung Delivers Invited Lecture at the National University of Singapore

2023-01-15

CEO Hyo-Il Jung Delivers Invited Lecture at the National University of Singapore
The DABOM Inc. Selected as a Participant in KOICA’s CTS Program

2022-12-01

The DABOM Inc. Selected as a Participant in KOICA’s CTS Program
CEO Hyo-Il Jung of The DABOM Inc. Receives Minister’s Award from the Ministry of Science and ICT

2022-07-07

CEO Hyo-Il Jung of The DABOM Inc. Receives Minister’s Award from the Ministry of Science and ICT
The DABOM Inc. signs MOU with ACTIVON Co., Ltd. for the development of plant-derived exosome materia

2022-03-22

The DABOM Inc. signs MOU with ACTIVON Co., Ltd. for the development of plant-derived exosome materia
We have opened a new homepage!

2021-12-02

We have opened a new homepage!
close